Loading clinical trials...
Loading clinical trials...
A Multicenter, Randomized, Double-blind, Placebo-controlled, Phase-II Trial to Assess Safety, and Efficacy of Sovateltide in the Treatment of Hypoxic-ischemic Encephalopathy in Neonates
Conditions
Interventions
Normal Saline along with standard treatment
Sovateltide along with standard treatment
Locations
4
India
Father Muller Medical College Hospital
Mangalore, Karnataka, India
Christian Medical College and Hospital
Ludhiana, Punjab, India
Niloufer Hospital
Hyderabad, Telangana, India
GSVM Medical College
Kanpur, Uttar Pradesh, India
Start Date
September 6, 2023
Primary Completion Date
November 1, 2026
Completion Date
December 1, 2026
Last Updated
December 31, 2025
NCT06448780
NCT02544100
NCT06098833
NCT06427642
NCT04602325
NCT05836610
Lead Sponsor
Pharmazz, Inc.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions